Lugol's Solution (1.5%): Clinical Trials

1 trial of Lugol's Solution (1.5%), newest first
ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1

Follow Lugol's Solution (1.5%): new trials by email Literature Review of Lugol's Solution (1.5%) trials Research Report on Lugol's Solution (1.5%)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RFA to Prevent Metachronous Squamous Neoplasia Recurrence After Complete Endoscopic Submucosal Dissection
Radiofrequency ablation, Endoscopy, Lugol's Solution (1.5%) - Esophageal Squamous Cell Neoplasm		Not applicableRecruitingE-DA Hospital1002016-04-182023-03-03

Conditions studied

Esophageal Neoplasms (1)  ·  Recurrence (1)

Sponsors

E-DA Hospital (1)

Countries

Taiwan (1)

Results publications

PMID 11474389, PMID 12297767, PMID 19340732, PMID 19474425, PMID 20669074, PMID 21455869, PMID 21679712, PMID 21839994, PMID 22423666, PMID 24668102, PMID 25257127, PMID 25668428, PMID 26656367, PMID 39521094